Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Talofen
Synonyms :
Lonazolaco, lonazolac
Class :
Analgesic, Anti-inflammatory, Nonsteroidal anti-inflammatory drug, acetic acid derivatives
Dosage Forms & StrengthsÂ
TabletÂ
25 mgÂ
50 mgÂ
75 mgÂ
100 mgÂ
Adult oral dosage is upto 600 milligrams (mg) daily in two divided doses for symptomatic treatment of upper respiratory tract, genitourinary, and osteoarticular INFLAMMATION and PAIN of various etiologies
A single 100 to 200 mg dose is sufficient for minimal pain
As with other nonsteroidal anti-inflammatory medicines (NSAIDs), an initial 2- to 3-week period on recommended dosage may be required to maximum symptomatic relief, following which dosage should be lowered to the lowest effective level achievable
Dose Adjustments
Limited data is available
Safety and efficacy are not seen in pediatricsÂ
Refer to the adult dosingÂ
lonazolac may reduce the elimination rate of abacavir, resulting in a greater serum level
when lonazolac is coupled with abciximab, the risk or severity of bleeding and hemorrhage is enhanced
lonazolac may reduce the elimination rate of aclidinium, resulting in a greater serum level
when antrafenine is taken with lonazolac, the chance or severity of undesirable effects can be enhanced
when zolmitriptan is coupled with lonazolac, the risk or severity of hypertension can be enhanced
lonazolac may reduce the elimination rate of vancomycin, resulting in a greater serum level
when used with lonazolac, the therapeutic efficacy of unoprostone can be reduced
Actions and Spectrum:Â
Actions:Â
Lonazolac, like other nonsteroidal anti-inflammatory medicines (NSAIDs), works largely by inhibiting the activity of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2.Â
Spectrum:Â
Lonazolac’s mechanism of action is similar to that of other nonsteroidal anti-inflammatory medicines (NSAIDs) in that it primarily works by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin synthesis. Lonazolac has the following actions: anti-inflammatory, analgesic (pain reliever), and antipyretic (fever reducer).Â
Frequency not definedÂ
Allergic skin reactionsÂ
HeadacheÂ
DrowsinessÂ
DizzinessÂ
NauseaÂ
VomitingÂ
Stomach discomfortÂ
Black Box Warning:Â
N/AÂ Â
Contraindication/Caution:Â
ContraindicationsÂ
CautionsÂ
Pregnancy consideration:Â Â
No data is available regarding the administration of the drug during pregnancy.Â
Breastfeeding warnings:Â Â
No data is available regarding the excretion of drug in breast milk.Â
Pregnancy category:Â
Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: No data is available for the drug under this category.Â
Pharmacology:Â
Lonazolac’s pharmacology is linked to its classification as a nonsteroidal anti-inflammatory medication (NSAID). Lonazolac, like other NSAIDs, works pharmacologically by inhibiting cyclooxygenase (COX) enzymes, resulting in a decrease in prostaglandin synthesis.Â
Pharmacodynamics:Â
Lonazolac suppresses COX enzyme activity, specifically COX-1 and COX-2. These enzymes are critical in the creation of prostaglandins, which are lipid molecules implicated in the inflammatory response, pain signaling, and body temperature regulation.Â
Pharmacokinetics:Â
AbsorptionÂ
Lonazolac is commonly taken orally in the form of tablets or capsules. It is absorbed from the gastrointestinal system and reaches the bloodstream after oral intake. Absorption rates and extents vary between individuals and may be altered by the presence of food. Â
DistributionÂ
Lonazolac enters the bloodstream and is transported to many tissues throughout the body. NSAIDs, such as lonazolac, have a relatively large volume of distribution, implying that they can permeate tissues, particularly inflamed tissues. Â
MetabolismÂ
Lonazolac may go through metabolic processes in the liver, though specifics concerning its metabolism are lacking. Metabolites can be formed as a result of metabolism. Â
Elimination and ExcretionÂ
Lonazolac’s elimination half-life varies between individuals and may be affected by factors like as age, renal function, and liver function. In general, the elimination half-life of NSAIDs is several hours. Lonazolac and its metabolites are mostly eliminated by the kidneys. Factors such as renal function influence the rate of elimination. Some metabolites may be eliminated through the urine.Â
Administration:Â
Lonazolac is normally administered by taking the medication by mouth in the form of tablets or capsules. Lonazolac is usually taken with or after a meal to lessen the risk of gastrointestinal adverse effects.
This is also known as “administer with food.” With a full glass of water, swallow the lonazolac tablets or capsules whole. Unless otherwise directed by your healthcare provider, do not crush, chew, or break the pills.Â
Patient information leafletÂ
Generic Name: lonazolacÂ
Pronounced: Loh-nah-zoh-lakÂ
Why do we use lonazolac?Â
Lonazolac is a nonsteroidal anti-inflammatory medication (NSAID) with anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-lowering) activities. It was largely given to treat inflammatory and pain-related illnesses.Â